Strengthening a workforce for innovative regulatory science in therapeutics development workshop summary /
Wedi'i Gadw mewn:
Awduron Corfforaethol: | Institute of Medicine (U.S.). Forum on Drug Discovery, Development, and Translation, Institute of Medicine (U.S.). Board on Health Sciences Policy, ebrary, Inc |
---|---|
Awduron Eraill: | Olsen, Steve, Claiborne, Anne B. |
Fformat: | Electronig eLyfr |
Iaith: | Saesneg |
Cyhoeddwyd: |
Washington, D.C. :
National Academies Press,
2012.
|
Pynciau: | |
Mynediad Ar-lein: | An electronic book accessible through the World Wide Web; click to view |
Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|
Eitemau Tebyg
Challenges for the FDA the future of drug safety : workshop summary /
Cyhoeddwyd: (2007)
Cyhoeddwyd: (2007)
Emerging safety science workshop summary /
Cyhoeddwyd: (2008)
Cyhoeddwyd: (2008)
Installation qualification of IBM systems and storage for FDA regulated companies
gan: Bradburn, James R.
Cyhoeddwyd: (2003)
gan: Bradburn, James R.
Cyhoeddwyd: (2003)
Building a national framework for the establishment of regulatory science for drug development workshop summary /
Cyhoeddwyd: (2011)
Cyhoeddwyd: (2011)
Assuring data quality and validity in clinical trials for regulatory decision making workshop report : Roundtable on Research and Development of Drugs, Biologics, and Medical Devices /
Cyhoeddwyd: (1999)
Cyhoeddwyd: (1999)
Public health effectiveness of the FDA 510(k) clearance process balancing patient safety and innovation : workshop report /
Cyhoeddwyd: (2010)
Cyhoeddwyd: (2010)
Development and approval of combination products a regulatory perspective /
Cyhoeddwyd: (2008)
Cyhoeddwyd: (2008)
Reputation and power organizational image and pharmaceutical regulation at the FDA
gan: Carpenter, Daniel P., 1967-
Cyhoeddwyd: (2010)
gan: Carpenter, Daniel P., 1967-
Cyhoeddwyd: (2010)
Public health effectiveness of the FDA 510(k) clearance process balancing patient safety and innovation : workshop report /
Cyhoeddwyd: (2011)
Cyhoeddwyd: (2011)
The future of drug safety promoting and protecting the health of the public /
Cyhoeddwyd: (2007)
Cyhoeddwyd: (2007)
Evaluation of certain veterinary drug residues in food sixty-sixth report of the Joint FAO/WHO Expert Committee on Food Additives.
Cyhoeddwyd: (2006)
Cyhoeddwyd: (2006)
Accelerating the development of biomarkers for drug safety workshop summary /
Cyhoeddwyd: (2009)
Cyhoeddwyd: (2009)
Establishing precompetitive collaborations to stimulate genomics-driven product development workshop summary /
Cyhoeddwyd: (2011)
Cyhoeddwyd: (2011)
Development of FDA-regulated medical products : a translational approach /
gan: Whitmore, Elaine
Cyhoeddwyd: (2012)
gan: Whitmore, Elaine
Cyhoeddwyd: (2012)
Allied health workforce and services workshop summary /
Cyhoeddwyd: (2011)
Cyhoeddwyd: (2011)
Risk-characterization framework for decision-making at the food and drug administration
Cyhoeddwyd: (2011)
Cyhoeddwyd: (2011)
Therapeutic justice and addicted parents a family treatment court evaluation /
gan: McMillin, Heidee, 1964-
Cyhoeddwyd: (2012)
gan: McMillin, Heidee, 1964-
Cyhoeddwyd: (2012)
The risks of prescription drugs
Cyhoeddwyd: (2010)
Cyhoeddwyd: (2010)
Therapeutic delivery solutions /
Cyhoeddwyd: (2014)
Cyhoeddwyd: (2014)
Adverse drug event reporting the roles of consumers and health-care professionals : workshop summary /
Cyhoeddwyd: (2007)
Cyhoeddwyd: (2007)
Enhancing food safety the role of the Food and Drug Administration /
Cyhoeddwyd: (2010)
Cyhoeddwyd: (2010)
Rational therapeutics for infants and children workshop summary /
Cyhoeddwyd: (2000)
Cyhoeddwyd: (2000)
Understanding the benefits and risks of pharmaceuticals workshop summary, Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy /
Cyhoeddwyd: (2007)
Cyhoeddwyd: (2007)
Acceptable risks politics, policy, and risky technologies /
gan: Heimann, C. F. Larry (Clarence Fredrick)
Cyhoeddwyd: (1997)
gan: Heimann, C. F. Larry (Clarence Fredrick)
Cyhoeddwyd: (1997)
Residue evaluation of certain veterinary drugs : Joint FAO/WHO Expert Committee on Food Additives, 75th meeting, Rome, Italy, 8-17 November 2011.
Cyhoeddwyd: (2012)
Cyhoeddwyd: (2012)
Innovation and the pharmaceutical industry critical reflections on the virtues of profit /
Cyhoeddwyd: (2008)
Cyhoeddwyd: (2008)
Food labelling the FDA's role in the selection of healthy foods /
Cyhoeddwyd: (2009)
Cyhoeddwyd: (2009)
Building a resilient workforce opportunities for the Department of Homeland Security, workshop summary /
Cyhoeddwyd: (2012)
Cyhoeddwyd: (2012)
Enhancing the regulatory decision-making approval process for direct food ingredient technologies workshop summary /
Cyhoeddwyd: (1999)
Cyhoeddwyd: (1999)
Development of therapeutic agents handbook
Cyhoeddwyd: (2012)
Cyhoeddwyd: (2012)
Drug trade, trafficking and policies
Cyhoeddwyd: (2011)
Cyhoeddwyd: (2011)
Toxicological evaluation of certain veterinary drug residues in food
Cyhoeddwyd: (2009)
Cyhoeddwyd: (2009)
WHO Expert Committee on Specifications for Pharmaceutical Preparations fortieth report.
Cyhoeddwyd: (2006)
Cyhoeddwyd: (2006)
WHO Expert Committee on Specifications for Pharmaceutical Preparations thirty-ninth report.
Cyhoeddwyd: (2005)
Cyhoeddwyd: (2005)
WHO Expert Committee on Specifications for Pharmaceutical Preparations forty-first report.
Cyhoeddwyd: (2007)
Cyhoeddwyd: (2007)
Breakthrough business models drug development for rare and neglected diseases and individualized therapies : workshop summary /
Cyhoeddwyd: (2009)
Cyhoeddwyd: (2009)
Absorption and drug development solubility, permeability, and charge state /
gan: Avdeef, Alex
Cyhoeddwyd: (2012)
gan: Avdeef, Alex
Cyhoeddwyd: (2012)
Understanding the demand for illegal drugs
Cyhoeddwyd: (2010)
Cyhoeddwyd: (2010)
Drug-drug interactions in pharmaceutical development
Cyhoeddwyd: (2008)
Cyhoeddwyd: (2008)
Post-genomic approaches in drug and vaccine development /
Cyhoeddwyd: (2015)
Cyhoeddwyd: (2015)
Eitemau Tebyg
-
Challenges for the FDA the future of drug safety : workshop summary /
Cyhoeddwyd: (2007) -
Emerging safety science workshop summary /
Cyhoeddwyd: (2008) -
Installation qualification of IBM systems and storage for FDA regulated companies
gan: Bradburn, James R.
Cyhoeddwyd: (2003) -
Building a national framework for the establishment of regulatory science for drug development workshop summary /
Cyhoeddwyd: (2011) -
Assuring data quality and validity in clinical trials for regulatory decision making workshop report : Roundtable on Research and Development of Drugs, Biologics, and Medical Devices /
Cyhoeddwyd: (1999)